Taylor and Francis Group, Journal of Enzyme Inhibition and Medicinal Chemistry, 5(22), p. 632-637
DOI: 10.1080/14756360701485562
Full text: Download
The synthesis of new bisaryl thienocyclopentoxazolidine derivatives was achieved through a Suzuki cross-coupling procedure with the aim to enhance the previously reported cytotoxicity of the series. The biological activity, evaluated in the NCI's in vitro human disease-oriented tumor cell line screening panel, was however partially conserved by the pharmacomodulations.